Top Authors

• Most frequent coverage on NBS

• 
  ChinaBio Today (336 followers)

  • Week in Review: Major Investments in China Biotech Companies (Sun, Nov 8)
  • NeoStem Closes China Biopharma Acquisition to Boost Revenues (Tue, Nov 3)
  • China Biotech Week in Review: Cross-Border Deals (Sun, Oct 11)

  More by ChinaBio Today on NBS »
• 
  Mike Havrilla (1920 followers)

  • NeoStem: A 3-Part China Merger Strategy (Thu, Oct 8)
  • NeoStem: Pending Merger Key to China Growth Strategy (Thu, Sep 17)
  • NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy (Fri, Jun 5)

  More by Mike Havrilla on NBS »

• Most followed authors on NBS

• 
  Mike Havrilla (1920 followers)

  • NeoStem: A 3-Part China Merger Strategy (Thu, Oct 8)
  • NeoStem: Pending Merger Key to China Growth Strategy (Thu, Sep 17)
  • NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy (Fri, Jun 5)

  More by Mike Havrilla on NBS »
• 
  ChinaBio Today (336 followers)

  • Week in Review: Major Investments in China Biotech Companies (Sun, Nov 8)
  • NeoStem Closes China Biopharma Acquisition to Boost Revenues (Tue, Nov 3)
  • China Biotech Week in Review: Cross-Border Deals (Sun, Oct 11)

  More by ChinaBio Today on NBS »

• Newest authors on NBS

• 
  ChinaBio Today (336 followers)

  • Week in Review: Major Investments in China Biotech Companies (Sun, Nov 8)
  • NeoStem Closes China Biopharma Acquisition to Boost Revenues (Tue, Nov 3)
  • China Biotech Week in Review: Cross-Border Deals (Sun, Oct 11)

  More by ChinaBio Today on NBS »
• 
  Mike Havrilla (1920 followers)

  • NeoStem: A 3-Part China Merger Strategy (Thu, Oct 8)
  • NeoStem: Pending Merger Key to China Growth Strategy (Thu, Sep 17)
  • NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy (Fri, Jun 5)

  More by Mike Havrilla on NBS »

• Most commented on NBS

• 
  Mike Havrilla (1920 followers)

  • NeoStem: A 3-Part China Merger Strategy (Thu, Oct 8)
  • NeoStem: Pending Merger Key to China Growth Strategy (Thu, Sep 17)
  • NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy (Fri, Jun 5)

  More by Mike Havrilla on NBS »
• 
  ChinaBio Today (336 followers)

  • Week in Review: Major Investments in China Biotech Companies (Sun, Nov 8)
  • NeoStem Closes China Biopharma Acquisition to Boost Revenues (Tue, Nov 3)
  • China Biotech Week in Review: Cross-Border Deals (Sun, Oct 11)

  More by ChinaBio Today on NBS »